Table of Contents
This research aims to provide an in-depth analysis of the European ultrasound market. It analyses the revenue potential, market dynamics and trends across countries in Central and Eastern Europe (CEE) and Western Europe as a combined European market. The European ultrasound market revenues have been derived from studying the dynamics of the different segments in ultrasound that include radiology, ob/gyn, cardiology, surgical, and others. The ultrasound market has also been segmented based on geographies. This study provides an analysis of the competition in the European ultrasound market, different companies that are participants in this market, and their product profiles. The study also mentions the key companies to watch for.
Key Questions This Study Will Answer
What is the revenue by sale of ultrasound systems to European customers each year from 2009 to
2013, and how is this figure expected to change through 2019?
What proportions of ultrasound market revenue were contributed by each of the x different
segments, and how are these proportions expected to change through 2019?
What proportions of ultrasound market revenue were contributed by each country considered in
the scope of this study, and how are these proportions expected to change through 2019?
How are the different drivers and restraints expected to impact the ultrasound market dynamics in
different countries across Western Europe and CEE?
Which competitors held the highest revenue market shares within the total European ultrasound
market in 2013? How is the competition going to impact the market dynamics?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Frontier Pharma: Versatile Innovation in Immunology - Large Therapy Area Pipeline with a High Degree of Repositioning Potential Summary Immunology is a large therapy area characterized by disorders of ...
Frontier Pharma: Head and Neck Cancer - Immunotherapies and Signal Transduction Inhibitors Dominate First-in-Class Innovation Summary Head and neck cancer (HNC) is the sixth most common malignancy worldwide, ...
“Medical Laboratory Testing Services reaches 12 billion tests per year. Genomic technology and China healthcare expansion driving global growth.....” Report Overview: A market that just keeps on growing. ...